Menu

Haemonetics Corporation HAE

Full chart Compare
Set alert

Price alert · HAE

All alert types
119.93 USD -4.18 (-3.37%)

At closeNov 6, 2026, 5:31 PM EST

119.93 0.00 0.00%

After hours · Nov 6, 5:31 PM ET

116.79 Day range 123.75
52.24 52-week range 127.42
YTD
+49.63%
1 year
+78.71%

Revenue & Expenses

Revenue by
United States → Revenue: $982.18MRevenue → Gross Profit: $743.59MGross Profit → Net Income: $97.31MGross Profit → Selling, General & Admin: $442.42MRevenue → Cost of Revenue: $590.44MGross Profit → Research & Development: $59.77MGross Profit → Interest Expense: $28.70MGross Profit → Other Expenses: $84.67MGross Profit → Income Tax: $30.72MEurope → Revenue: $185.02MAsia → Revenue: $87.21MJapan → Revenue: $68.20MOther Country or Region → Revenue: $11.42MGross Profit$743.59MCost of Revenue$590.44MNet Income$97.31MSelling, General & Admin$442.42MResearch & Development$59.77MInterest Expense$28.70MOther Expenses$84.67MIncome Tax$30.72MRevenue$1.33BUnited States$982.18MEurope$185.02MAsia$87.21MJapan$68.20MOther Country or Region$11.42M

Latest period ending Mar 28, 2026 · select a line to chart its full history

HAE annual income statement
Fiscal yearFY 2026 Mar 28, 2026FY 2025 Mar 29, 2025FY 2024 Mar 30, 2024FY 2023 Apr 1, 2023FY 2022 Apr 2, 2022
1.33B1.36B1.31B1.17B993.20M
787.59M748.96M691.55M615.10M505.50M
154.85M198.79M164.88M156.03M80.75M
97.31M167.68M117.56M115.40M43.38M
2.053.312.292.240.84
HAE annual balance sheet
Fiscal yearFY 2026 Mar 28, 2026FY 2025 Mar 29, 2025FY 2024 Mar 30, 2024FY 2023 Apr 1, 2023FY 2022 Apr 2, 2022
245.44M306.76M178.80M284.47M259.50M
2.40B2.45B2.20B1.93B1.86B
1.60B1.63B1.24B1.12B1.11B
1.22B1.22B807.79M765.89M773.59M
796.32M820.84M959.96M818.00M749.42M
HAE annual cash flow
Fiscal yearFY 2026 Mar 28, 2026FY 2025 Mar 29, 2025FY 2024 Mar 30, 2024FY 2023 Apr 1, 2023FY 2022 Apr 2, 2022
293.22M181.72M181.75M273.06M172.26M
-179.55M-161.90M-322.39M-143.79M-86.34M
-178.46M108.82M38.16M-100.36M-15.75M
-83.30M-37.14M-64.49M-108.58M-94.49M
-61.32M127.96M-105.67M24.97M67.19M